DexComDXCM +1.18%90 Net Margin % is 16.74% as of Mar. 2026, which is 63% above its 10-year median of 10.30. GuruFocus rates DXCM with a GF Score™ of 90/100 and a GF Value™ of $103.54 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, DexCom ranks better than 88.49% on this metric.
Net margin is calculated as Net Income divided by its Revenue. DexCom's Net Income for the
three
months ended in Mar. 2026 was $200 Mil. DexCom's Revenue for the
three
months ended in Mar. 2026 was $1,192 Mil. Therefore, DexCom's net margin for the quarter that ended in Mar. 2026 was 16.74%.
The historical rank and industry rank for DexCom's Net Margin % or its related term are showing as below:
DXCM'
s Net Margin % Range Over the Past 10 Years
Min: -12.32 Med: 10.3 Max: 25.62
Current: 19.31
DXCM's Net Margin % is ranked better than 88.49% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs DXCM: 19.31
DexCom (NAS:DXCM) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
DexCom Net Margin % Related Terms
DexCom Net Margin % Historical Data
* Premium members only.
The historical data trend for DexCom's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DexCom's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexCom Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Net Margin % distribution charts can be found below:
* The bar in red indicates where DexCom's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom (DXCM) has a Net Margin % of 16.74% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on DexCom and its competitors. This is 63% above median its historical median of 10.30. According to the industry distribution chart, DexCom ranks #94 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 11.5%.
Is DexCom's Net Margin % too high?
DexCom's current Net Margin % of 16.74% is 63% above median its 10-year median of 10.30. The Medical Devices & Instruments industry median Net Margin % is 2.07. DexCom's value of 16.74% is 708.7% above this industry median. Based on the distribution chart, DexCom ranks #94 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, DexCom has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Net Margin % compare to GEHC and STE?
According to the Medical Devices & Instruments industry distribution chart, DexCom ranks #94 out of 817 companies for Net Margin %. This places DexCom in the top 12% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. DexCom's value of 16.74% is 708.7% above this benchmark. While the company's 10-year median is 10.30 vs. the industry median of 2.07, DexCom has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DexCom's current Net Margin % of 16.74% is 708.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on DexCom and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DexCom's current Net Margin % is 16.74%, which is 63% above median its own 10-year median of 10.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Significantly Undervalued. The stock's GF Value™ is $103.54, compared to a current price of $69.75 — trading 32.6% below its estimated fair value. The current Net Margin % is 16.74%, which is 63% above median its 10-year median of 10.30 and 708.7% above the Medical Devices & Instruments industry median of 2.07. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For DexCom (DXCM), the current Net Margin % is 16.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DexCom (DXCM) Overvalued in 2026?
Based on GuruFocus' analysis, DexCom stock appears to be undervalued.
The current stock price of $69.75 is trading 32.6% below its estimated GF Value™ of $103.54.
GuruFocus considers DexCom to be Significantly Undervalued.
Key valuation signals for DXCM:
Net Margin %: 16.74% (63% above median its 10-year median of 10.30)
GF Value™: $103.54 vs. price of $69.75 (32.6% below fair value)
Industry Position: 708.7% above the Medical Devices & Instruments median (#94 of 817)
No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score
Get the complete analysis for DXCM
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DXCM has been successfully added to your 
